Editor,

There has been growing recognition of the challenges of Alzheimer’s disease, but the funding to find a cure lags dramatically behind what’s necessary.

In 2010, Congress unanimously passed legislation that set a goal of finding a treatment for Alzheimer’s by 2025.

But National Institutes of Health (NIH) research on dementia has not increased to the $2 billion a year level that scientists say is needed.

In fact, for every $100 spent on Alzheimer’s research, Medicare and Medicaid programs spend $26,000 to care for people with the disease.

Currently, there are 100,000 Washingtonians living with Alzheimer’s disease, and that number will grow to 140,000 by 2025. We must invest more to find a treatment and a cure now.

The U.S. Senate Appropriations Committee approved a bill giving $350 million more to the NIH for Alzheimer’s research, while the House Committee has voted $300 million. If even the lower figure is signed into law, that would be a 50 percent increase in research funding for this disease.

These issues concern me deeply, having been witness to my deceased wife’s battle with Alzheimer’s illness for more than a dozen years.

In the course of being the primary caregiver to my wife, I met many other people dealing with the many issues of practical, personal, social and financial hardships. It would take a book to explain in detail the extent of these experiences.

I urge Sen. Patty Murray and Sen. Maria Cantwell, as well as U.S. Rep. Rick Larsen, to vote for this vital Alzheimer’s research boost and push to make sure it is in the final appropriations bill enacted into law.

Ivan Neaigus

Langley